OBJECTIVES: Comparisons of sympathetic nervous system activity (SNA) between young and older women have produced equivocal results, in part due to inadequate control for potential differences in sex hormone concentrations, age, and body composition. The aim of the present study was to determine the effect of a short-term reduction in sex hormones on tonic skeletal muscle sympathetic nerve activity (MSNA), an indirect measure of whole body SNA, using an experimental model of sex hormone deficiency in young women. We also assessed the independent effects of estradiol and progesterone add-back therapy on MSNA. METHODS: MSNA was measured in 9 women (30±2 years; mean±SE) on three separate occasions: during the mid-luteal menstrual cycle phase, on the fifth day of gonadotropin-releasing hormone antagonist (GnRHant) administration, and after 5 days add-back of either estradiol (n=4) or progesterone (n=3) during continued GnRHant administration. RESULTS: In response to GnRHant, there were significant reductions in serum estradiol and progesterone (both p<0.01) and MSNA (25.0±1.9 vs. 19.2±2.4 bursts/min, p=0.04). Continued GnRHant plus add-back estradiol or progesterone resulted in a nonsignificant decrease (19.2±1.7 vs. 12.1±1.9 bursts/min, p=0.07) or increase (16.2±1.7 vs. 21.0±6.0 bursts/min, p=0.39), respectively, in MSNA when compared with GnRHant alone. INTERPRETATION: The findings of this preliminary study suggest that short-term ovarian hormone suppression attenuates MSNA and that this may be related to the suppression of progesterone rather than estradiol.
OBJECTIVES: Comparisons of sympathetic nervous system activity (SNA) between young and older women have produced equivocal results, in part due to inadequate control for potential differences in sex hormone concentrations, age, and body composition. The aim of the present study was to determine the effect of a short-term reduction in sex hormones on tonic skeletal muscle sympathetic nerve activity (MSNA), an indirect measure of whole body SNA, using an experimental model of sex hormone deficiency in young women. We also assessed the independent effects of estradiol and progesterone add-back therapy on MSNA. METHODS: MSNA was measured in 9 women (30±2 years; mean±SE) on three separate occasions: during the mid-luteal menstrual cycle phase, on the fifth day of gonadotropin-releasing hormone antagonist (GnRHant) administration, and after 5 days add-back of either estradiol (n=4) or progesterone (n=3) during continued GnRHant administration. RESULTS: In response to GnRHant, there were significant reductions in serum estradiol and progesterone (both p<0.01) and MSNA (25.0±1.9 vs. 19.2±2.4 bursts/min, p=0.04). Continued GnRHant plus add-back estradiol or progesterone resulted in a nonsignificant decrease (19.2±1.7 vs. 12.1±1.9 bursts/min, p=0.07) or increase (16.2±1.7 vs. 21.0±6.0 bursts/min, p=0.39), respectively, in MSNA when compared with GnRHant alone. INTERPRETATION: The findings of this preliminary study suggest that short-term ovarian hormone suppression attenuates MSNA and that this may be related to the suppression of progesterone rather than estradiol.
Authors: M García-Durán; T de Frutos; J Díaz-Recasens; G García-Gálvez; A Jiménez; M Montón; J Farré; L Sánchez de Miguel; F González-Fernández; M D Arriero; L Rico; R García; S Casado; A López-Farré Journal: Circ Res Date: 1999-11-26 Impact factor: 17.367
Authors: M B Monroe; D R Seals; L F Shapiro; C Bell; D Johnson; P Parker Jones Journal: Am J Physiol Endocrinol Metab Date: 2001-05 Impact factor: 4.310
Authors: Edward L Melanson; Kathleen M Gavin; Karen L Shea; Pamela Wolfe; Margaret E Wierman; Robert S Schwartz; Wendy M Kohrt Journal: J Appl Physiol (1985) Date: 2015-09-03
Authors: Charlotte W Usselman; Chantelle A Nielson; Torri A Luchyshyn; Tamara I Gimon; Nicole S Coverdale; Stan H M Van Uum; J Kevin Shoemaker Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-10-12 Impact factor: 3.619
Authors: Charlotte W Usselman; Tamara I Gimon; Chantelle A Nielson; Torri A Luchyshyn; Nicole S Coverdale; Stan H M Van Uum; J Kevin Shoemaker Journal: Am J Physiol Heart Circ Physiol Date: 2014-12-19 Impact factor: 4.733
Authors: Dain W Jacob; Aaron M Voshage; Jennifer L Harper; Jacqueline K Limberg Journal: Am J Physiol Heart Circ Physiol Date: 2022-04-29 Impact factor: 5.125
Authors: Ronee E Harvey; Emma C Hart; Nisha Charkoudian; Timothy B Curry; Jason R Carter; Qi Fu; Christopher T Minson; Michael J Joyner; Jill N Barnes Journal: Hypertension Date: 2015-06-22 Impact factor: 10.190